One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Cancer consequences of the HIV funding crisis
doi : 10.1016/S1470-2045(25)00722-3
Volume 27, Issue 1, January 2026, Page 1
Is PORTEC-4a the tipping point in endometrial cancer management?
Has the limit been reached in treatment of unresectable oesophageal squamous cell carcinoma?
Artificial intelligence in pancreatic cancer detection: from premise to practice
The promise of scalable symptom surveillance with stepped collaborative care in oncology
De-escalation of adjuvant radiotherapy in HPV-associated oropharyngeal cancer
Retraction and republication—De-escalation of adjuvant radiotherapy in HPV-associated oropharyngeal cancer
The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer
The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer
The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer – Authors' reply
Study links ultra-processed food consumption with bowel polyps in women younger than 50 years
Gavi hits HPV vaccine milestone early but concerns surround future funding
UK–US drug pricing deal to cost NHS £3 billion as NICE increases new medicines threshold
Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study
Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial
Cancer mortality rates by detailed occupation among US working-age adults between 2020 and 2023: a population-based study
First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
Artificial intelligence and radiologists in pancreatic cancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study
Electronic health record-facilitated symptom surveillance and collaborative care intervention in oncology (E2C2): a cluster-randomised, population-level, stepped-wedge, pragmatic trial
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment
International consensus recommendations and alignment of terminology for the histopathological diagnosis of extranodal extension in head and neck squamous cell carcinoma: an HN-CLEAR initiative
Development of a core outcome set for adolescents and young adults with cancer
High-output cardiac failure from a synovial sarcoma mimicking arteriovenous fistula
